Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Phys ; 33(1): 19-33, 2007 Feb.
Article in English | MEDLINE | ID: mdl-19669550

ABSTRACT

The correlation behavior in the heart beat rate significantly differs with respect to light sleep, deep sleep, and REM sleep. We investigate whether fluctuations of the heart beat rhythm may serve as a surrogate parameter for rapidly changing sleep phenomena, and if these changes are accessible by progressive beat-by-beat analysis of the sleep electrocardiogram (ECG).

2.
Cortex ; 41(4): 464-70, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16042023

ABSTRACT

Children with language processing deficits have various learning impairments and poor scholastic performance. In 3-10% of all children a specific language processing deficit can be identified by the Sound Connecting Sub-Test of the Illinois Test of Psycholinguistic-Abilities (SC-ITPA). These children among which we drew our index group (AS-Group) suffer from the disability to recognize isolated sounds as parts of words. Following linguistic terminology this is known as an auditory sequential sound processing deficit (ASSPD) Eighteen children (AS-Group) and 21 controls (C-Group) were subjected to mapped P300 evoked potential analyses of cortical response to acoustic stimulation in the oddball paradigm. The data presented here show that there exists significant relation between the P300 amplitude reduction and ASSPD. The P300 amplitude decrease measured in the AS-Group is due to a reduced information transmission in accordance with Johnson's Triarchic Model of the P300 Amplitude. The cerebral structures involved in poor language processing are localized at the left temporo-parietal cortex. This supports the hypothesis that the underlying neuronal defect of ASSPD is localized in the language center and not in the auditory pathway. The P300 amplitude may serve as electrophysiological tool to identify ASSPD and to quantify the degree of improvement in the course of specific therapy.


Subject(s)
Auditory Perceptual Disorders/diagnosis , Event-Related Potentials, P300/physiology , Language Disorders/diagnosis , Learning Disabilities/diagnosis , Reaction Time/physiology , Speech Perception/physiology , Auditory Perception/physiology , Auditory Perceptual Disorders/physiopathology , Child , Child, Preschool , Female , Functional Laterality/physiology , Humans , Language Disorders/physiopathology , Learning Disabilities/physiopathology , Male , Mental Processes/physiology , Psychophysics
3.
Pharmacology ; 70(4): 206-15, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15001822

ABSTRACT

Bupropion (BUP), which in its slow-release formulation (Zyban) is used as a smoking-cessation drug, increases dopamine overflow in the nucleus accumbens and serves as a reinforcer in animal experiments, both suggesting that BUP may possess some abuse liability. The present study examined if BUP produced subjective effects indicative of abuse liability in a quasi-naturalistic setting, with caffeine (CAF) serving as a positive control. In a randomized double-blind crossover design, male smokers (n = 50) ingested two doses (interdosing interval, 6 h) of placebo (PLC), 178 mg CAF, or 150 mg slow-release BUP in their normal mid-week work environment. They completed questionnaires administered by telephone at regular intervals. CAF significantly increased ratings of 'pleasant effects' (p = 0.008) and 'high' (p = 0.03), whereas BUP produced a 'high' of only very moderate size (p = 0.02). In 3 subjects each, BUP or CAF produced ratings of 'pleasant effects' that were >9-fold higher than those for PLC. Finally, BUP increased the number of cigarettes smoked by 29% (i.e., from 24 to 31 per day; p = 0.004) only in those subjects who were unable to report any effect of either BUP or CAF. CAF had no effect on cigarette consumption. These findings suggest that BUP, like CAF, might be of some abuse liability in a small subgroup of smokers (i.e., 6% each of the present sample), and it may transiently increase, rather than decrease, smoking during early phases of treatment in continuing smokers.


Subject(s)
Affect/drug effects , Antidepressive Agents, Second-Generation/pharmacology , Bupropion/pharmacology , Caffeine/pharmacology , Central Nervous System Stimulants/pharmacology , Adolescent , Adult , Aged , Antidepressive Agents, Second-Generation/administration & dosage , Antidepressive Agents, Second-Generation/pharmacokinetics , Bupropion/administration & dosage , Bupropion/pharmacokinetics , Caffeine/pharmacokinetics , Central Nervous System Stimulants/pharmacokinetics , Cotinine/urine , Cross-Over Studies , Delayed-Action Preparations , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Middle Aged , Smoking/psychology , Smoking Cessation , Substance-Related Disorders/psychology , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...